BioStock: Immunicum changes name to Mendus

The biotech company previously known as Immunicum is now operated and traded under the name Mendus. The company, that develops immunotherapies for cancer patients with tumour recurrence, believes that the new name reflects its maturity and its long-term ambitions.

Read the article at biostock.se:

https://www.biostock.se/en/2022/06/immunicum-changes-name-to-mendus/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/